Stocks · News reference
GLJ Research Reiterates Buy on Cleveland-Cliffs, Maintains $15.6 Price Target
GLJ Research analyst Gordon L. Johnson reiterates Cleveland-Cliffs (NYSE:CLF) with a Buy and maintains $15.6 price target.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Charles Schwab, UnitedHealth And Cleveland-Cliffs: CNBC’s ‘Final Trades’
CNBC final trades: Pros picked Schwab, Cleveland-Cliffs, UnitedHealth and Incyte; shares posted mixed moves Wednesday.
CNBC Halftime Report Final Trades: Charles Schwab, Cleveland-Cliffs, UnitedHealth Group, Incyte